Does Chlorella Cholesterol Meta-Analysis work?

Updated July 2026

Quick Answer

Chlorella Cholesterol Meta-Analysis has evidence relevant to strength of evidence and what the studies can or cannot prove, but conclusions should stay close to the cited sources. One representative finding is: However, the overall certainty of evidence was low to very low according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework, limiting confidence in these findings.

Key Takeaways

  • 01However, the overall certainty of evidence was low to very low according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework, limiting confidence in these findings. [Jafari A (2026)]
  • 02This systematic review and meta-analysis was conducted to investigate the effects of Chlorella supplementation on cardiometabolic health indicators in individuals with overweight or obesity. [Jafari A (2026)]
  • 03A systematic search of PubMed, Scopus, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials was conducted up to November 2024. [Jafari A (2026)]
  • 04vulgaris) consumption on cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease (NAFLD). [Jafari A (2026)]
The current Migaku evidence database contains 2 reusable source documents for Chlorella Cholesterol Meta-Analysis. This answer focuses on strength of evidence and what the studies can or cannot prove. - However, the overall certainty of evidence was low to very low according to the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework, limiting confidence in these findings. [Jafari A (2026); evidence level 1] - This systematic review and meta-analysis was conducted to investigate the effects of Chlorella supplementation on cardiometabolic health indicators in individuals with overweight or obesity. [Jafari A (2026); evidence level 1] - A systematic search of PubMed, Scopus, Embase, Web of Science, and the Cochrane Central Register of Controlled Trials was conducted up to November 2024. [Jafari A (2026); evidence level 1] - vulgaris) consumption on cardiovascular disease risk factors in patients with non-alcoholic fatty liver disease (NAFLD). [Jafari A (2026); evidence level 1] - However, all included studies were conducted in Iran, limiting the generalizability of these findings, and the certainty of evidence was rated as very low due to risk of bias, indicating that the results should be interpreted with caution. [Jafari A (2026); evidence level 1] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Sources

  1. Does <i>Chlorella</i> Supplementation Improve Adiposity, Metabolic Dysfunction, and Oxidative Stress in Individuals With Excess Weight? A Systematic Review and Meta-Analysis.
  2. The beneficial effects of Chlorella vulgaris supplementation on health-related indices in patients with non-alcoholic fatty liver disease: a GRADE-assessed systematic review and meta-analysis.